Cairo - Mubasher: The Arab Drug Company (ADCO) generated higher net profits after tax at EGP 182.61 million in the first eight months (8M) of fiscal year (FY) 2025/2026.
The positive income during the period from 1 July 2025 to 28 February 2026 was compared with EGP 154.95 million in 8M-24/25.
Furthermore, the net profits before tax jumped year-on-year (YoY) to EGP 235.63 million in 8M-25/26 from EGP 199.94 million, according to the company’s financial indicators.
ADCO generated net sales of EGP 924.14 million in the July 2025-February 2026 period, which marked an annual hike from EGP 756.76 million.
